PSMA-specific CAR-engineered T cells eradicate disseminated prostate cancer in preclinical models.
Zuccolotto G, Fracasso G, Merlo A, Montagner IM, Rondina M, Bobisse S, Figini M, Cingarlini S, Colombatti M, Zanovello P, Rosato A.
Zuccolotto G, et al. Among authors: colombatti m.
PLoS One. 2014 Oct 3;9(10):e109427. doi: 10.1371/journal.pone.0109427. eCollection 2014.
PLoS One. 2014.
PMID: 25279468
Free PMC article.